Lysophosphatidylcholines: Bioactive lipids generated during storage of blood components

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 1, 2012, Pages 55-60

  Maślanka, Krystyna ^a   Smoleńska Sym, Gabriela ^a   Michur, Halina ^a   Wróbel, Agnieszka ^a   Lachert, Elzbieta ^a   Brojer, Ewa ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Bioactive lipids; Lysophosphatidylcholines; Storage of blood components; TRALI

Indexed keywords

INTERLEUKIN 8; LYSOPHOSPHATIDYLCHOLINE;

ARTICLE; BLOOD DONOR; BLOOD STORAGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIPID ANALYSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

ACUTE LUNG INJURY; BLOOD PRESERVATION; BLOOD TRANSFUSION; HUMANS; LIPIDS; LYSOPHOSPHATIDYLCHOLINES; NEUTROPHIL ACTIVATION;

EID: 84858797020     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-011-0154-x     Document Type: Article

References (38)

1. (2010) Guide to the Preparation, Use and Quality Assurance of Blood Components; Recommendation No. R (95) 15; 16th Edition. European Directorate for the Quality of Medicines & Health Care of the Council of Europe. http://www.centronazionalesangue.it/sites/.../guida-edqm-16-edizione.pdf
2. Bux J (2005) Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 89:1-10
3. Bux J, Sachs UJ (2007) The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136:788-799 (Pubitemid 46348408)
4. Cunningham TJ, Yao L, Lucena A (2008) Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines unexpected therapeutic properties. J Inflamm 5:17
5. Fuchs B, Schiller J (2009) Lysophospholipids: their generation, physiological role and detection. Are they importanat disease markers? Mini Rev Med Chem 9:368-378
6. Goldman M, Webert KE, Amold DM et al. (2005) Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 19:2-31 (Pubitemid 40248500)
7. Holness L, Knippen MA, Simmons L et al (2004) Fatalities caused by TRALI. Transfus Med Rev 18:184-188 (Pubitemid 38962487)
8. Khan H, Belsher J, Yilmaz M et al (2007) Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patient. Chest 131:1308-1314 (Pubitemid 46762333)
9. Kopko PM, Marshall CS, MacKenzie MR et al (2002) Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 287:1968-1971 (Pubitemid 34309755)
10. Lin P, Welch EJ, Gao XP et al (2005) Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 174:2981-2989 (Pubitemid 40279718)
11. Looney MR, Matthay MA (2006) Animal models of transfusion-related acute lung injury. Crit Care Med 34(5 suppl):S132-S136 (Pubitemid 43670480)
12. Maślanka K, Michur H, Z- upańska B et al (2007) Leukocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang 92:247-249
13. Popovsky MA, Haley NR (2000) Further characterization of transfusion- related acute lung injury: demographics, clinical and laboratory features, and morbidity. Immunohematology 16:157-159
14. Popovsky MA, Moore SB (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25:573-577 (Pubitemid 16174471)
15. Popovsky MA, Abel MD, Moore SB (1983) Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 128:185-189 (Pubitemid 13073563)
16. Reil A, Keller-Stanislawski B, Gunay S et al (2008) Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang 95:313-317
17. Ruebsaamen K, Liebiesch G, Boettcher A et al (2010) Lipidomic analysis of platelet senescence. Transfusion 50:1665-1676
18. Sachs UJ, Weissmann N, Wasel W et al (2010) Supernatants from stored leukodepleted packed red blood cells do not regulary exhibit changes in their lyso-phosphatidylcholine composition and do not cause TRALI in an ex vivo rat lung model. Vox Sang 99(Suppl 1):456
19. Silliman CC, McLaughlin NJ (2006) Transfusion-related acute lung injury. Blood Rev 20:139-159
20. Silliman CC, Clay KL, Thurman GW et al (1994) Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 124:684-694
21. Silliman CC, Dickey WO, Paterson AJ et al (1996) Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 36:133-139 (Pubitemid 26070876)
22. Silliman CC, Paterson AJ, Dickey WO et al (1997) The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37:719-726 (Pubitemid 27297612)
23. Silliman CC, Voelkel NF, Allard JD et al (1998) Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101:1458-1467 (Pubitemid 28166844)
24. Silliman CC, Bjornsen AJ, Tuder R et al (2000) Pre-storage leukoreduction of packed red blood cells inhibits transfusion related acute lung injury (TRALI) in an animal model. Blood 96:655a
25. Silliman CC, Bjornsen AJ, Wyman TH et al (2003a) Plasma and lipids from stored platelets case acute lung injury in an animal model. Transfusion 43:633-640 (Pubitemid 36506360)
26. Silliman CC, Boshkov LK, Mehdizadehkashi Z et al (2003b) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factor. Blood 101:454-462 (Pubitemid 36077563)
27. Silliman CC, Fung YL, Ball JB et al (2009) Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions. Blood Rev 23:245-255
28. Silliman CC, Moore EE, Kelher MR et al (2011) Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion. doi:10.1111/j.1537-2995.2011. 03186.x
29. Stainsby D, Jones H, Asher D et al (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20:273-282 (Pubitemid 44428107)
30. Thompson JS, Severson CD, Parmely MJ et al (1971) Pulmonary "hypersensitivity" reactions induced by transfusion of non-HLA leukoaglutinins. N Engl J Med 284:1120-1125
31. Van Stein D, Beckers EA, Sintnicolaas K et al (2010) Transfusion-related acute lung injury in the Netherlands: an observational study. Transfusion 50:213-220
32. Vlaar AP, Hofstra JJ, Kulik W et al (2010a) Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 116:1360-1368
33. Vlaar AP, Hofstra JJ, Levi M et al (2010b) Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a 'Two-Hit' in vivo syngeneic transfusion model. Anesthesiology 113:92-103
34. Vlaar AP, Hofstra JJ, Determann RM et al (2011a) The incidence, risk factors and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case control study. Blood 117:4219-4225
35. Vlaar AP, Kulik W, Nieuwland R et al (2011b) Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 51:2358-2366
36. Ward HN (1970) Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 73:689-694
37. Weerheim AM, Kolb AM, Sturk A et al (2002) Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performence thin-layer chromatography. Anal Biochem 302:191-198 (Pubitemid 34229723)
38. Żupańska B, Uhrynowska M, Michur H et al (2007) Transfusion-related acute lung injury and leukocyte-reacting antibodies. Vox Sang 93:70-77 (Pubitemid 46850710)